Skip to main content

Advertisement

Figure 3 | Trials

Figure 3

From: A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial

Figure 3

Fluorescence-activated cell sorting analysis of virus-specific T cells (Tvis). An example of cytomegalovirus (CMV)-Tvis is shown. FITC Fluorescein; FSC (forward scatter; IFN, interferon; SSC sideward scatter.

Back to article page